Castle Biosciences, Inc.
CSTL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $18,245 | -$57,466 | -$67,138 | -$31,292 |
| Dep. & Amort. | $15,997 | $12,330 | $10,543 | $3,407 |
| Deferred Tax | $1,401 | -$223 | -$1,877 | -$8,736 |
| Stock-Based Comp. | $50,320 | $51,219 | $36,321 | $21,740 |
| Change in WC | -$14,125 | -$6,630 | -$7 | -$4,102 |
| Other Non-Cash | -$6,972 | -$4,856 | -$19,497 | $0 |
| Operating Cash Flow | $64,866 | -$5,626 | -$41,655 | -$18,983 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$28,326 | -$13,621 | -$5,632 | -$3,483 |
| Net Acquisitions | $18 | $0 | -$26,966 | $0 |
| Inv. Purchases | -$205,729 | -$189,075 | -$134,689 | $0 |
| Inv. Sales/Matur. | $183,900 | $186,500 | $0 | $0 |
| Other Inv. Act. | $0 | $13 | $742 | -$63,174 |
| Investing Cash Flow | -$50,137 | -$16,183 | -$166,545 | -$66,657 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $9,903 | -$142 | -$122 | -$8 |
| Stock Issued | $2,017 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$5,781 | -$2,156 | $1,637 | $5,429 |
| Financing Cash Flow | $6,139 | -$2,298 | $1,515 | $5,421 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $20,868 | -$24,107 | -$206,685 | -$80,219 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $98,841 | $122,948 | $329,633 | $409,852 |
| End Cash | $119,709 | $98,841 | $122,948 | $329,633 |
| Free Cash Flow | $36,540 | -$19,247 | -$47,287 | -$22,466 |